References
- Segal, S.J.; Croxatto, H.B. Single Administration of Hormones for Long Term Control of Reproductive Function; XXIII Meeting of American Fertility Society: Washington, DC, 1967.
- Croxatto, H.B. Levonorgestrel-releasing contraceptive implant.Ann. Med. 1993, 25, 155–160., [PUBMED], [INFOTRIEVE]
- Klein, J. Smart polymer solutions.Nature 2000, 405, 745–747., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kost, J.; Lapidot, S.A. Wise, D.LSmart polymers for controlled drug delivery. In Handbook of Pharmaceutical Controlled Release Technology; ., Ed.; Marcel Dekker, Inc.: New York, 2000; 65–87.
- Kikuchi, A.; Okano, T. Pulsatile drug release control using hydrogels.Adv. Drug Deliv. Rev. 2002, 54, 53–77., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dunn, R.L.; English, J.P.; Cowsar, D.R.; Vanderbilt, D.P. Biodegradable In Situ Forming Implants and Methods of Producing the Same. US Patent 4,938,763, 1990.
- Shively, M.L.; Bennett, A.T.; Coonts, B.A.; Renner, W.D.; Southard, J.L. Physico-chemical characterization of polymeric injectable implant delivery system.J. Control. Release 1995, 33, 237–243., [CROSSREF]
- Dunn, R.L.; Tipton, A.J. Polymeric Compositions Useful as Controlled Release Implants. US patent 5,702,716, 1997.
- Eliaz, R.E.; Kost, J. Characterization of a polymeric PLGA-injectable implant delivery system for thecontrolled release of proteins.J. Biomed. Mater. Res. 2000, 50, 388–396., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wang, L.; Kleiner, L.; Venkatraman, S. Structure formation in injectable poly (lactide-co-glycolide) depots.J. Control. Release 2003, 90, 345–354., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jackson, J.K.; Zhang, X.; Llewelllen, S.; Hunter, W.L.; Burt, H.M. The characterization of novel polymeric paste formulations for intratumoral delivery.Int. J. Pharm. 2004, 270, 185–198., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pratten, M.K.; Lloyd, J.B.; Horpel, G.; Ringsdorf, H. Micelle-forming block copolymers: pinocytosis by macrophages and interaction with model membranes.Makromol. Chem. Phys. 1985, 186, 725–733., [CROSSREF]
- Jeong, B.; Bae, Y.H.; Kim, S.W. Biodegradable thermosensitive micelles of PEG-PLGA-PEG triblock copolymers.Colloids Surf., B Biointerfaces 1999, 16, 185–193., [CROSSREF]
- Jeong, B.; Bae, Y.H.; Kim, S.W. Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers.J. Control. Release 2000, 63, 155–163., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kim, Y.J.; Choi, S.; Koh, J.J.; Lee, M.; Ko, K.S.; Kim, S.W. Controlled release of insulin from injectable biodegradable triblock copolymer.Pharm. Res. 2001, 18, 548–550., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zentner, G.M.; Rathi, R.; Shih, C.; McRea, J.C.; Seo, M.H.; Oh, H.; Rhee, B.G.; Mestecky, J.; Moldoveanu, Z.; Morgan, M.; Weitman, S. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs.J. Control. Release 2001, 72, 203–215., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gao, Z.; Shukla, H.; Johnson, J.R.; Crowley, W.R. Controlled release of a contraceptive steroid from biodegradable and injectable gel formulations: in vitro evaluation.Pharm. Res. 1995, 12, 857–863., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kim, D.D.; Kim, J.L.; Chien, Y.W. Mutual hairless rat skin permeation-enhancing effect of ethanol/water system and oleic acid.J. Pharm. Sci. 1996, 85, 1191–1195., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chen, G.S.; Kim, D.D.; Chien, Y.W. Dual-controlled transdermal delivery of levonorgestrel and estradiol: enhanced permeation and modulated delivery.J. Control. Release 1995, 34, 129–143., [CROSSREF]
- Ye, W.; Chien, Y.W. Dual-controlled drug delivery across biodegradable copolymer. I. Delivery kinetics of levonorgestrel and estradiol through (caprolactone/lactide) block copolymer.Pharm. Dev. Technol. 1996, 1, 1–9., [PUBMED], [INFOTRIEVE], [CSA]
- Catz, P.; Friend, D.R. Transdermal delivery of levonorgestrel VIII. Effects of enhancers on rat skin, hairless mouse skin, hairless guinea pig and human skin.Int. J. Pharm. 1990, 58, 93–102., [CROSSREF]
- Vora, B.; Khopade, A.J.; Jain, N.K. Proniosome based transdermal delivery of levonorgestrel for effective contraception.J. Control. Release 1998, 54, 149–165., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fitzgerald, J.F.; Corrigan, O.I. Investigation of the mechanism governing the release of levamisole from polylactide-co-glycolide delivery systems.J. Control. Release 1996, 42, 125–132., [CROSSREF]
- Hsu, Y.Y.; Gresser, J.D.; Stewart, R.R.; Trantolo, D.J.; Lyons, C.M.; Simons, G.A.; Gangadharam, P.R.J.; Wise, D.L. Mechanisms of sioniazid release from poly (D, L-lactide-co-glycolide) matrices prepared by dry-mixing and low density polymeric foam methods.J. Pharm. Sci. 1996, 85, 706–713., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Athanasiou, K.A.; Niederauer, G.G.; Agrawal, C.M. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers.Biomaterials 1996, 17, 93–102., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Asano, M.; Fukuzaki, H.; Yoshida, M.; Kumakura, M.; Mashimo, T.; Yuasa, H.; Imai, K.; Yamanaka, H.; Suzuki, K. In-vivo characterization of low molecular weight copoly (lactic acid/glycolic acid) formulations with controlled release of luteinizing hormone-releasing hormone agonist.J. Control. Release 1989, 9, 111–122., [CROSSREF]
- Chi, S.C.; Jun, H.W. Release rates of ketoprofen from poloxamer gels in a membraneless diffusion cell.J. Pharm. Sci. 1991, 80, 280–283., [PUBMED], [INFOTRIEVE]
- Gilbert, J.C.; Hadgraft, J.; Bye, A.; Brookes, L.G. Drug release from Pluronic F-127 gels.Int. J. Pharm. 1986, 32, 223–228., [CROSSREF]
- Hatefi, A.; Amsden, B. Biodegradable injectable in situ forming drug delivery systems.J. Control. Release 2002, 80, 9–28., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Packhaeuser, C.B.; Schnieders, J.; Oster, C.G.; Kissel, T. In situ forming parenteral drug delivery systems: an overview.Eur. J. Pharm. Biopharm. 2004, 58, 445–455., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gu, Z.; Ye, W.; Yang, J.; Li, Y.; Chen, X.; Zhong, X.; Feng, X. Biodegradable block copolymer matrices for long-acting contraceptives with constant release.J. Control. Release 1992, 22, 3–14., [CROSSREF]
- Sung, K.C.; Han, R.; Hu, O.Y.P.; Hsu, L. Controlled release of nalbuphine prodrugs from biodegradable polymeric matrices: influence of prodrug hydrophilicity and polymer composition.Int. J. Pharm. 1998, 172, 17–25., [CROSSREF]
- Matsumoto, J.; Nakada, Y.; Sakurai, K.; Nakamura, T.; Takahashi, Y. Preparation of nanoparticles consisted of poly (L-lactide)–poly (ethylene glycol)–poly (L-lactide) and their evaluation in vitro.Int. J. Pharm. 1999, 185, 93–101., [PUBMED], [INFOTRIEVE], [CROSSREF]